Skip to main content
SpringerLink
Log in

Pembrolizumab gets thumbs up in the UK and Australia

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Australian dollars

References

  1. Australian Government Department of Health. New drug listing Keytruda to treat melanoma. Internet Document : 1 Sep 2015. Available from: URL: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley109.htm

  2. NICE. NICE recommends pembrolizumab for advanced skin cancer. Media Release : 7 Sep 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pembrolizumab gets thumbs up in the UK and Australia. PharmacoEcon Outcomes News 736, 34 (2015). https://doi.org/10.1007/s40274-015-2444-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2444-8

Search

Navigation